Cargando…
CD5L, Macrophage Apoptosis Inhibitor, Was Identified in Epicardial Fat-Secretome and Regulated by Isoproterenol From Patients With Heart Failure
OBJECTIVES: Neurohormonal dysfunction, which can regulate epicardial fat activity, is one of the main promoters of atrial fibrillation (AF) in patients with heart failure (HF). Our aim was to study the epicardial fat mediators for AF in patients with HF and its catecholaminergic regulation. METHODS:...
Autores principales: | Agra-Bermejo, Rosa M., Cacho-Antonio, Carla, Rozados-Luis, Adriana, Couselo-Seijas, Marinela, Fernandez, Angel L., Martinez-Cereijo, J. M., Bravo, S. B., Gonzalez-Juanatey, Jose R., Eiras, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338428/ https://www.ncbi.nlm.nih.gov/pubmed/32695009 http://dx.doi.org/10.3389/fphys.2020.00620 |
Ejemplares similares
-
A New Biomarker Tool for Risk Stratification in “de novo” Acute Heart Failure (OROME)
por: Agra-Bermejo, Rosa M., et al.
Publicado: (2022) -
Inflammatory and lipid regulation by cholinergic activity in epicardial stromal cells from patients who underwent open‐heart surgery
por: Couselo‐Seijas, Marinela, et al.
Publicado: (2020) -
Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value
por: Almengló, Cristina, et al.
Publicado: (2021) -
Nutrients restriction upregulates adiponectin in epicardial or subcutaneous adipose tissue: impact in de novo heart failure patients
por: Agra, Rosa M, et al.
Publicado: (2018) -
Myocardium Metabolism in Physiological and Pathophysiological States: Implications of Epicardial Adipose Tissue and Potential Therapeutic Targets
por: Gandoy-Fieiras, Nerea, et al.
Publicado: (2020)